A Phase II Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 10 Jul 2017
At a glance
- Drugs Oxaliplatin (Primary) ; Gemcitabine; Paclitaxel
- Indications Germ cell and embryonal neoplasms; Testicular cancer
- Focus Therapeutic Use
- 05 Jul 2017 Status changed from active, no longer recruiting to completed.
- 25 Mar 2015 Planned End Date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
- 25 Mar 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.